You can only be hopefull SRF but the structure of ANP's registry has altered drastically over the period of its existence. Pharma wont be eyeing the amount ISIS put into ANP when coming to decisions though - as always it's based soley on the drug candidates & implied value to them in question. Referance points are pointless based on sums paid in the past.
Anyway i think it's getting a bit of track - whatever happens will happen with time - as it does.
You can only be hopefull SRF but the structure of ANP's registry...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $49.85K | 497.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101000 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 282099 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |